About me...
H-index: 45 (Web Of Science)
ORCID: 0000-0001-7698-0760
ResearcherID: A-1727-2017
Striking Achievements
- A donor and recipient candidate gene association study of allograft loss in renal transplant recipients receiving a tacrolimus-based regimen, Am. J. Transplant., (2018), 10.1111/ajt.14894
- Activity of the Calcineurin Pathway in Patients on the Liver Transplantation Waiting List: Factors of Variability and Response to Tacrolimus Inhibition, Clin. Chem., 63 (2017), 1734-1744
- Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients, Pharmacol. Res., 129 (2018), 84-94
- Population Pharmacokinetics and Bayesian Estimators for Refined Dose Adjustment of a New Tacrolimus Formulation in Kidney and Liver Transplant Patients, Clin. Pharmacokinet., 56 (2017), 1491-1498
- Corticosteroid-Sparing and Optimization of Mycophenolic Acid Exposure in Liver Transplant Recipients Receiving Mycophenolate Mofetil and Tacrolimus: A Randomized, Multicenter Study, Transplantation, 100 (2016) 1705-1713
- Since 2011: Head of Dpt Pharmacology-toxicology University Hospital of Limoges
- Since 2001: Professor of Pharmacology, Faculty of Medicine of Limoges and Dpt Pharmacology-toxicology University Hospital of Limoges
- 1998-2001: Associate Professor of Pharmacology, Faculty of Medicine of Limoges and Dpt Pharmacology-toxicology University Hospital of Limoges
- 1992-1998: Hospital Practitioner, Dpt Pharmacology-toxicology University Hospital of Limoges
- 1988-1992: Assistant Professor of Physiology, Faculty of Medicine of Limoges and Dpt Physiology University Hospital of Limoges
Awards
- 1995: Young Investigator Award, French Society of Analytical Toxicology (SFTA)
- 2001: Young Investigator Award, International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT)
- 2009: C.E. Pippenger Award for outstanding contributions to Therapeutic Drug Monitoring (IATDMCT)
Invited Conferences
- 157 invited conferences of which 98 on academic and 59 on industrial invitations (76 in France and 81 abroad)
Positions in Learned Societies
- President of EACPT (European Association for Clinical Pharmacology and Therapeutics),
- President of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) 2011-2013 and past-president 2013-2015
European Consortia
- Coordinator of the FP7 “BIOMARGIN” European consortium (2012-2018)
- Member of the ERACOSYSMED “ROCKET” European consortium (2018-2020)
Consensus Conferences
- Participated in 5 (and coordinated 2) international consensus conferences about clinical outcomes, immunosuppressive drugs and biomarkers in transplantation, with 6 recommendation papers published
- 1986 MD degree, Faculty of Medicine, Limoges, France
- 1988 Master degree, Université Paris V, Paris
- 1992 PhD degree, Université Paris V, Paris
- 1998 HDR (habilitation to mentor PhD students), Université de Limoges
Supervision
- Supervision or co-supervision of 17 PhD theses and many more master degree students
Teaching
- Coordinator of basic and clinical pharmacology teaching at Faculty of Medicine, University of Limoges
- Teaching activities in several master courses in France
- Since 1999: Head of a research team in pharmacology (DEXO, then UMR850 and then UMR1248), see below
- Since 2011: Head of the Dpt of Pharmacology-Toxicology, Limoges University Hospital
- 2007-2011: President of the coordination committee for medical research (CRBSP), Limoges
- 2010-2016: Vice-President of the board of directors, in charge of research, Limoges University Hospital
- 2011-2017: Director of the shared platform of mass spectrometry, University of Limoges
RESEARCH ACTIVITIES
Since 2018:
- Head of the UMR1248 research team “IPPRITT” (individual Prediction and Prevention of Risks with Immunosuppressive Therapies and Transplantations) appointed by INSERM, University and Limoges and University Hospital of Limoges
2007-2017:
- Head of the UMR850 research team “PIST” (Pharmacology of Immunosuppressants in transplantation) appointed by INSERM, University and Limoges and University Hospital of Limoges
1999-2007:
- Head of the DEXO research team (fate and effects of xenobiotics), University of Limoges
